270 related articles for article (PubMed ID: 8813627)
1. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
Varga G; Scarpignato C
Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
[TBL] [Abstract][Full Text] [Related]
3. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
4. Effects of evodiamine on gastrointestinal motility in male rats.
Wu CL; Hung CR; Chang FY; Lin LC; Pau KY; Wang PS
Eur J Pharmacol; 2002 Dec; 457(2-3):169-76. PubMed ID: 12464363
[TBL] [Abstract][Full Text] [Related]
5. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
Green T; Dimaline R; Peikin S; Dockray GJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang JL; Wang PS
Pflugers Arch; 2002 Nov; 445(2):187-93. PubMed ID: 12457239
[TBL] [Abstract][Full Text] [Related]
7. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
Scarpignato C; Kisfalvi I; D'Amato M; Varga G
Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
[TBL] [Abstract][Full Text] [Related]
8. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Scand J Gastroenterol; 2002 Oct; 37(10):1133-9. PubMed ID: 12408516
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
Taniguchi H; Yazaki N; Yomota E; Shikano T; Endo T; Nagasaki M
Eur J Pharmacol; 1996 Sep; 312(2):227-33. PubMed ID: 8894600
[TBL] [Abstract][Full Text] [Related]
12. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
13. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
Wu CL; Doong ML; Wang PS
Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
16. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
17. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
[TBL] [Abstract][Full Text] [Related]
18. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
19. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
[TBL] [Abstract][Full Text] [Related]
20. Ceruletide suppresses rotational behavior in lesioned rats via CCKA receptors.
Fujisawa M; Miyamoto O; Itano T; Tokuda M; Matsui H; Nagao S; Negi T; Hatase O
Eur J Pharmacol; 1993 Jul; 238(1):127-30. PubMed ID: 8405076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
